価格表

在庫・価格 : 2024年06月08日 13時17分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
gp130, Soluble, Human, Recombinant
データシート
228-GP-050 RSDアールアンドディー システムス
R&D Systems, Inc.
50 μg ¥261,000
(未発注)
追加

在庫・価格 : 2024年06月08日 13時17分 現在

gp130, Soluble, Human, Recombinant

  • 商品コード:228-GP-050
  • メーカー:RSD
  • 包装:50μg
  • 価格: ¥261,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Hurst SM et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001 Jun;14(6):705-14
Hurst SM et al
2001/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
2 Erices A et al. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. Exp. Cell Res. 2002 Oct;280(1):24-32
Erices A et al
2002/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
3 Richards PJ et al. Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis. Arthritis Rheum. 2006 May;54(5):1662-72
Richards PJ et al
2006/01/01
Species: Human, Application: ELISA capture, Sample type: Serum PubMed
4 Brenn D et al. Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain. Arthritis Rheum. 2007 Jan;56(1):351-9
Brenn D et al
2007/01/01
Application: Bioassay PubMed
5 Kino T et al. 3-O-Formyl-20R,21-epoxyresibufogenin suppresses IL-6-type cytokine actions by targeting the glycoprotein 130 subunit: potential clinical implications. J. Allergy Clin. Immunol. 2007 Aug;120(2):437-44
Kino T et al
2007/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
6 Appenheimer MM et al. Conservation of IL-6 trans-signaling mechanisms controlling L-selectin adhesion by fever-range thermal stress. Eur. J. Immunol. 2007 Oct;37(10):2856-67
Appenheimer MM et al
2007/01/01
Species: Chicken, Fish - Rainbow Trout, Human, Mouse, Application: Bioassay, Sample type: Whole Cells PubMed
7 Ahmed S et al. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proc. Natl. Acad. Sci. U.S.A. 2008 Sep;105(38):14692-7
Ahmed S et al
2008/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
8 Chollangi S et al. A unique loop structure in oncostatin M determines binding affinity toward oncostatin M receptor and leukemia inhibitory factor receptor. J. Biol. Chem. 2012 Sep;287(39):32848-59
Chollangi S et al
2012/01/01
Application: ELISA capture,Surface Plasmon Resonance, Sample Type: recombinant LIF, OSM, or gp130 PubMed
9 Cho SW et al. The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone. J. Biol. Chem. 2013 Mar;288(10):6814-25
Cho SW et al
2013/01/01
Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells PubMed
10 Meng J et al. Breakpoint Cluster Region-Mediated Inflammation Is Dependent on Casein Kinase II. J. Immunol. 2016 Oct;197(8):3111-3119
Meng J et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
11 K旦nig C et al. Involvement of Spinal IL-6 Trans-Signaling in the Induction of Hyperexcitability of Deep Dorsal Horn Neurons by Spinal Tumor Necrosis Factor-Alpha. J. Neurosci. 2016 Sep;36(38):9782-91
K旦nig C et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
12 Uchibori T et al. IL-6 trans-signaling is another pathway to upregulate Osteopontin. Cytokine 2017 Feb;90:88-95
Uchibori T et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
13 Tsukamoto H et al. Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression. Cancer Res. 2017 May;77(9):2279-2291
Tsukamoto H et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Hurst SM et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001 Jun;14(6):705-14
    Hurst SM et al
    2001/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Erices A et al. Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells. Exp. Cell Res. 2002 Oct;280(1):24-32
    Erices A et al
    2002/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Richards PJ et al. Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis. Arthritis Rheum. 2006 May;54(5):1662-72
    Richards PJ et al
    2006/01/01
  • 備考:
    Species: Human, Application: ELISA capture, Sample type: Serum
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Brenn D et al. Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain. Arthritis Rheum. 2007 Jan;56(1):351-9
    Brenn D et al
    2007/01/01
  • 備考:
    Application: Bioassay
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kino T et al. 3-O-Formyl-20R,21-epoxyresibufogenin suppresses IL-6-type cytokine actions by targeting the glycoprotein 130 subunit: potential clinical implications. J. Allergy Clin. Immunol. 2007 Aug;120(2):437-44
    Kino T et al
    2007/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Appenheimer MM et al. Conservation of IL-6 trans-signaling mechanisms controlling L-selectin adhesion by fever-range thermal stress. Eur. J. Immunol. 2007 Oct;37(10):2856-67
    Appenheimer MM et al
    2007/01/01
  • 備考:
    Species: Chicken, Fish - Rainbow Trout, Human, Mouse, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Ahmed S et al. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production. Proc. Natl. Acad. Sci. U.S.A. 2008 Sep;105(38):14692-7
    Ahmed S et al
    2008/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Chollangi S et al. A unique loop structure in oncostatin M determines binding affinity toward oncostatin M receptor and leukemia inhibitory factor receptor. J. Biol. Chem. 2012 Sep;287(39):32848-59
    Chollangi S et al
    2012/01/01
  • 備考:
    Application: ELISA capture,Surface Plasmon Resonance, Sample Type: recombinant LIF, OSM, or gp130
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Cho SW et al. The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone. J. Biol. Chem. 2013 Mar;288(10):6814-25
    Cho SW et al
    2013/01/01
  • 備考:
    Application: Bioassay,In Vivo, Sample Type: In Vivo,Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Meng J et al. Breakpoint Cluster Region-Mediated Inflammation Is Dependent on Casein Kinase II. J. Immunol. 2016 Oct;197(8):3111-3119
    Meng J et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    K旦nig C et al. Involvement of Spinal IL-6 Trans-Signaling in the Induction of Hyperexcitability of Deep Dorsal Horn Neurons by Spinal Tumor Necrosis Factor-Alpha. J. Neurosci. 2016 Sep;36(38):9782-91
    K旦nig C et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Uchibori T et al. IL-6 trans-signaling is another pathway to upregulate Osteopontin. Cytokine 2017 Feb;90:88-95
    Uchibori T et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Tsukamoto H et al. Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression. Cancer Res. 2017 May;77(9):2279-2291
    Tsukamoto H et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed